Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice

Biochemical and Biophysical Research Communications

Volumn 248, Issue 3, 1998, Pages 660-663

  Mitsumoto, Yasuhide ^a   Watanabe, Akihito ^a   Mori, Atsushi ^a   Koga, Nobuyuki ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

MPTP; Neurodegeneration; Nigrostriatal neurons; Parkinson's disease; Regeneration

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; NEUROTOXIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NERVE REGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0032581386     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.8986     Document Type: Article

References (18)

1. Heikkila R. E., Hess A., Duvoisin R. C. Science. 224:1984;1451-1453.
2. Tipton K. F., Singer T. P. J. Neurochem. 61:1993;1191-1206.
3. Vingerhoets F. J. G., Snow B. J., Tetrud J. W., Langston J. W., Schulzer M., Calne D. B. Ann. Neurol. 36:1994;765-770.
4. Gupta M., Wiener H. L. Neurochem. Res. 20:1995;385-389.
5. Przedbroski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L., Dowson T. M. Proc. Natl. Acad. Sci. U.S.A. 93:1996;4565-4571.
6. Sitoh T., Niijima K., Mizuno Y. J. Neurol. Sci. 77:1987;229-235.
7. Hallman H., Lange J., Olson L., Stromberg I., Jonsson G. J. Neurochem. 44:1985;117-127.
8. Date I., Felten D. L., Felten S. Y. Brain Res. 519:1990;266-276.
9. Ricaurte G. A., Delanney L. E., Irwin I., Langston J. W. Neuropharmacology. 26:1987;97-99.
10. Ricaurte G. A., Irwin I., Forno L. S., Delanney L. E., Langston E., Langston J. W. Brain Res. 403:1987;43-51.
11. Sundstrom E., Stromberg I., Tsutsumi T., Olson L., Jonsson G. Brain Res. 405:1987;26-38.
12. Schneider J. S., Yuwiler A. Exp. Neurol. 105:1989;177-183.
13. Tomac A., Lindqvist E., Lin L. H., Ogren S. O., Young D., Hoffer B. J., Olson L. Nature. 373:1995;335-339.
14. Steiner J. P., Hamilton G. S., Ross T. D., Valentine H. L., Guo H., Connolly M. A., Liang S., Ramsey C., Li J. J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A., Suzdak P. D. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2019-2024.
15. Sonsalla P. K., Heikkila R. E. Eur. J. Pharmacol. 129:1986;339-345.
16. Arai N., Misugi K., Goshima Y., Misu Y. Brain Res. 515:1990;57-63.
17. Miller G. W., Staley J. K., Heilman G. J., Perez J. T., Mash D. C., Rye D. B., Levey A. I. Ann. Neurol. 41:1997;530-539.
18. Jackson-Lewis V., Jakowec M., Burke R. E., Przedbroski S. Neurodegeneration. 4:1996;257-269.